Bourne Partners, headquartered in Charlotte, North Carolina, stands as a premier financial services firm with a dedicated focus on the pharmaceutical, pharma services, and consumer health sectors. Leveraging over 20 years of experience as both owners and operators, Bourne Partners delivers expert investment banking and advisory services, alongside strategic direct investment opportunities. The firm is committed to facilitating the efficient flow of capital within the global healthcare industry, ultimately striving to improve the health and well-being of partners and patients worldwide.
Bourne Partners operates through two synergistic business segments: Investment Banking and Strategic Capital.
Bourne Partners Investment Banking
The Investment Banking division of Bourne Partners offers a comprehensive suite of services tailored to the healthcare and life sciences sector. Serving both external clients and their own portfolio companies, they specialize in critical financial transactions. Their expertise encompasses mergers and acquisitions, managing both buy-side and sell-side engagements. Furthermore, Bourne Partners facilitates licensing and partnering opportunities, equity and debt capital raising, and provides strategic consulting to guide businesses towards optimal growth and financial health. The firm’s reputation is underscored by its collaborations with leading strategic and Private Equity firms, including Cerberus, Cinven, Irving Place Capital, and The Carlyle Group, demonstrating their capability to handle complex and high-profile deals.
Bourne Partners Strategic Capital
Bourne Partners Strategic Capital focuses on building partnerships and making strategic investments in pharmaceutical and pharmaceutical services companies. They actively seek opportunities where they can contribute long-term strategic value and foster sustainable growth. Their investment portfolio includes notable companies such as AMRI, Covis Pharma S.à.r.l., iNova Pharmaceuticals, Millicent Pharma, King Pharmaceuticals, Novitium Pharma, and WelldyneRx. These investments highlight Bourne Partners’ dedication to supporting innovation and expansion within the healthcare ecosystem.
Through its distinct yet interconnected divisions, Bourne Partners effectively bridges the gap between capital and opportunity within the healthcare sector. Their extensive experience and specialized focus position them as a valuable partner for companies seeking financial expertise and strategic guidance in the dynamic landscape of pharma and healthcare.
